ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Zealand Pharma AS (PK)

Zealand Pharma AS (PK) (ZLDPF)

86.75
0.00
(0.00%)
Closed April 19 4:00PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
86.75
Bid
82.48
Ask
88.39
Volume
47
0.00 Day's Range 0.00
32.415 52 Week Range 111.44
Market Cap
Previous Close
86.75
Open
-
Last Trade
1
@
84.955
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
3,292
Shares Outstanding
62,512,622
Dividend Yield
-
PE Ratio
-7.71
Earnings Per Share (EPS)
-11.26
Revenue
358.77M
Net Profit
-703.74M

About Zealand Pharma AS (PK)

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Soborg, Dnk
Founded
1970
Zealand Pharma AS (PK) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker ZLDPF. The last closing price for Zealand Pharma AS (PK) was $86.75. Over the last year, Zealand Pharma AS (PK) shares have traded in a share price range of $ 32.415 to $ 111.44.

Zealand Pharma AS (PK) currently has 62,512,622 shares outstanding. The market capitalization of Zealand Pharma AS (PK) is $5.42 billion. Zealand Pharma AS (PK) has a price to earnings ratio (PE ratio) of -7.71.

ZLDPF Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.51.7595307917985.2586.7582.94167384.63483088CS
4-13.76-13.6901800816100.5110382.94179193.30869694CS
1218.7527.573529411868111.4465.256329294.94850442CS
2644.61105.86141433342.14111.4440.4225187.48757787CS
5253.1157.8008915333.65111.4432.415169182.799149CS
15655.05173.65930599431.7111.4411.14135872.2304931CS
26066.48327.97237296520.27111.4411.14157557.98950522CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
RWODRedwoods Acquisition Corporation
$ 16.56
(107.09%)
193.21k
ZCMDZhongchao Inc
$ 2.60
(79.31%)
1.78M
WLGSWang and Lee Group Inc
$ 0.7249
(44.98%)
228.57k
HUBCHub Cyber Security Ltd
$ 1.65
(27.91%)
2.09M
GTIMGood Times Restaurants Inc
$ 2.99
(22.54%)
2
MBOTMicrobot Medical Inc
$ 0.36
(-59.55%)
5
BGLCBioNexus Gene Lab Corporation
$ 0.65
(-23.40%)
28.53k
TIRXTian Ruixiang Holdings Ltd
$ 0.6402
(-19.98%)
112.25k
ISPCiSpecimen Inc
$ 0.3392
(-19.43%)
90.62k
AGBAAGBA Group Holding Ltd
$ 0.88
(-14.56%)
243.71k
HUBCHub Cyber Security Ltd
$ 1.65
(27.91%)
2.09M
ZCMDZhongchao Inc
$ 2.60
(79.31%)
1.78M
SQQQProShares UltraPro Short QQQ
$ 12.37
(2.49%)
1.71M
SINTSiNtx Technologies Inc
$ 0.039
(-2.50%)
1.19M
SPCBSuperCom Ltd
$ 0.2834
(18.08%)
1.17M

ZLDPF Discussion

View Posts
Trading2retire Trading2retire 7 years ago
PR Release - FDA approval - Type II Diabetes.
👍️0
stocktrademan stocktrademan 9 years ago
$ZLDPF recent news/filings

bullish

## source: finance.yahoo.com

Mon, 14 Sep 2015 12:00:00 GMT ~ Sanofi Reports Positive Top-Line Results in Second Pivotal LixiLan Phase III Study

[PR Newswire] - PARIS, Sept. 14, 2015 /PRNewswire/ -- Sanofi announced today that the LixiLan-L Phase III clinical trial met its primary endpoint in patients with type 2 diabetes treated with insulin glargine with or without metformin. The fixed-ratio combination of insulin glargine 100 Units/mL and lixisenatide, a GLP-1 receptor agonist, demonstrated statistically superior reduction in HbA1c (average blood glucose over the previous three months) compared with insulin glargine 100 Units/mL. Overall, the fixed-ratio combination had a safety profile reflecting those of insulin glargine 100 Units/mL and lixisenatide.

read full: http://finance.yahoo.com/news/sanofi-reports-positive-top-line-120000569.html
*********************************************************

Wed, 29 Jul 2015 11:00:00 GMT ~ Sanofi Announces that First LixiLan Phase III Study Met Primary Endpoint

[PR Newswire] - PARIS, July 29, 2015 /PRNewswire/ -- Sanofi announced today that the LixiLan-O Phase III clinical trial met its primary objective in patients with type 2 diabetes treated with metformin. The fixed-ratio combination of insulin glargine 100 units/mL and lixisenatide, a GLP-1 RA, demonstrated statistically superior reduction in HbA1c (average blood glucose over the previous three months) compared with lixisenatide and compared with insulin glargine 100 units/mL. Overall, the fixed-ratio combination had a safety profile reflecting those of lixisenatide and insulin glargine 100 units/mL.

read full: http://finance.yahoo.com/news/sanofi-announces-first-lixilan-phase-110000971.html
*********************************************************

$ZLDPF charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com



$ZLDPF company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/ZLDPF/company-info
Ticker: $ZLDPF
OTC Market Place: OTC Pink Current
CIK code: 0001573728
Company name: Zealand Pharma A/S
Incorporated In:


$ZLDPF share structure

## source: otcmarkets.com

Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available

$ZLDPF extra dd links

Company name: Zealand Pharma A/S
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=ZLDPF+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=ZLDPF+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=ZLDPF+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/ZLDPF/news - http://finance.yahoo.com/q/h?s=ZLDPF+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/ZLDPF/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/ZLDPF/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=ZLDPF+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/ZLDPF
DTCC (dtcc.com): http://search2.dtcc.com/?q=Zealand+Pharma+A%2FS&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Zealand+Pharma+A%2FS
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Zealand+Pharma+A%2FS&x=0&y=0

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/ZLDPF
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001573728&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/ZLDPF/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/ZLDPF/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=ZLDPF&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=ZLDPF
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/ZLDPF/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=ZLDPF+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=ZLDPF+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=ZLDPF
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=ZLDPF
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=ZLDPF+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/ZLDPF/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=ZLDPF+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/ZLDPF.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=ZLDPF
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/ZLDPF/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/ZLDPF
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/ZLDPF
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/ZLDPF:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=ZLDPF
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=ZLDPF



$ZLDPF DD Notes ~ http://www.ddnotesmaker.com/ZLDPF
👍️0
stocktrademan stocktrademan 9 years ago
$ZLDPF recent news/filings

bullish

## source: finance.yahoo.com

no recent news found
*********************************************************

$ZLDPF charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com



$ZLDPF company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/ZLDPF/company-info
Ticker: $ZLDPF
OTC Market Place: Grey Market
CIK code: not found
Company name: Zealand Pharma A/S
Incorporated In:

Business Description:

$ZLDPF share structure

## source: otcmarkets.com

Market Value: $412,355,476 a/o Jun 10, 2015
Shares Outstanding: 22,870,520 a/o Dec 18, 2011
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available

$ZLDPF extra dd links

Company name: Zealand Pharma A/S
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=ZLDPF+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=ZLDPF+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=ZLDPF+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/ZLDPF/news - http://finance.yahoo.com/q/h?s=ZLDPF+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/ZLDPF/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/ZLDPF/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=ZLDPF+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/ZLDPF
DTCC (dtcc.com): http://search2.dtcc.com/?q=Zealand+Pharma+A%2FS&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Zealand+Pharma+A%2FS
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Zealand+Pharma+A%2FS&x=0&y=0

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/ZLDPF
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/ZLDPF/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/ZLDPF/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=ZLDPF&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=ZLDPF
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/ZLDPF/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=ZLDPF+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=ZLDPF+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=ZLDPF
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=ZLDPF
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=ZLDPF+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/ZLDPF/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=ZLDPF+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/ZLDPF.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=ZLDPF
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/ZLDPF/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/ZLDPF
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/ZLDPF
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/ZLDPF:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=ZLDPF
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=ZLDPF



$ZLDPF DD Notes ~ http://www.ddnotesmaker.com/ZLDPF
👍️0

Your Recent History

Delayed Upgrade Clock